Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Current Assets (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Current Assets data on record, last reported at $83.4 million in Q4 2025.

  • For Q4 2025, Current Assets fell 30.16% year-over-year to $83.4 million; the TTM value through Dec 2025 reached $83.4 million, down 30.16%, while the annual FY2025 figure was $83.4 million, 30.16% down from the prior year.
  • Current Assets reached $83.4 million in Q4 2025 per PLSE's latest filing, down from $97.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $120.9 million in Q1 2025 and bottomed at $22.2 million in Q1 2022.
  • Average Current Assets over 5 years is $64.1 million, with a median of $60.9 million recorded in 2021.
  • Peak YoY movement for Current Assets: plummeted 64.24% in 2022, then surged 297.08% in 2025.
  • A 5-year view of Current Assets shows it stood at $45.3 million in 2021, then skyrocketed by 37.11% to $62.1 million in 2022, then dropped by 27.06% to $45.3 million in 2023, then soared by 163.52% to $119.4 million in 2024, then crashed by 30.16% to $83.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $83.4 million in Q4 2025, $97.2 million in Q3 2025, and $108.2 million in Q2 2025.